J. Juárez

628 total citations
10 papers, 509 citations indexed

About

J. Juárez is a scholar working on Molecular Biology, Immunology and Allergy and Genetics. According to data from OpenAlex, J. Juárez has authored 10 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Immunology and Allergy and 2 papers in Genetics. Recurrent topics in J. Juárez's work include Cell Adhesion Molecules Research (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Protease and Inhibitor Mechanisms (2 papers). J. Juárez is often cited by papers focused on Cell Adhesion Molecules Research (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Protease and Inhibitor Mechanisms (2 papers). J. Juárez collaborates with scholars based in United States, Australia and Germany. J. Juárez's co-authors include Rebecca J. Gum, Douglas D. Boyd, Ernst Lengyel, H Wang, Carlos Simón, D. Barry Boyd, Andrew P. Mazar, Garth L. Nicolson, Gary L. Clayman and Hiroshi Sato and has published in prestigious journals such as Oncogene, British Journal of Cancer and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

J. Juárez

10 papers receiving 496 citations

Peers

J. Juárez
Comparison fields: 5 of 70
  • Molecular Biology 255
  • Cancer Research 250
  • Oncology 165
  • Immunology and Allergy 87
  • Hematology 51
Noriko Tanaka Japan
Taina Turpeenniemi-Hujanen Finland
Heidi Y. Shi United States
Jonathan Waxman United Kingdom
Meng‐Huee Lee United Kingdom
Junko Gotoh Japan
Hyun I. Park United States
A S Bajkowski United States
K M K Bottomley United Kingdom
Noriko Tanaka Japan View profile →
Citations per field, relative to J. Juárez
J. Juárez · 1×
Citations per year, relative to J. Juárez
J. Juárez · 1×

Countries citing papers authored by J. Juárez

Since Specialization
Citations

This map shows the geographic impact of J. Juárez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Juárez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Juárez more than expected).

Fields of papers citing papers by J. Juárez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Juárez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Juárez. The network helps show where J. Juárez may publish in the future.

Co-authorship network of co-authors of J. Juárez

This figure shows the co-authorship network connecting the top 25 collaborators of J. Juárez. A scholar is included among the top collaborators of J. Juárez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Juárez. J. Juárez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
# Title Journal Authors Indexed citations
1 Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224) British Journal of Cancer Fernando Doñate, J. Juárez et al. 60
2 132 POSTER Translation of in vitro markers of the anti-angiogenic and anti-tumor activity of the SOD1 inhibitor ATN-224 to clinical trials European Journal of Cancer Supplements Fernando Doñate, Sarah Lowndes et al. 1
3 Immunohistochemical characterisation of the monoclonal antibody BLCA-38 for the detection of prostate cancer Cancer Immunology Immunotherapy Pamela J. Russell, Kim Ow et al. 22
4 Design of novel N-(2,4-dioxo-1,2,3,4-tetrahydro-thieno[3,2-d]pyrimidin-7-yl)-guanidines as thymidine phosphorylase inhibitors, and flexible docking to a homology model Bioorganic & Medicinal Chemistry Letters J. Juárez, Fernando Doñate et al. 18
5 Stimulation of urokinase-type plasminogen activator receptor expression by PMA requires JNK1-dependent and -independent signaling modules Oncogene Rebecca J. Gum, J. Juárez et al. 42
6 Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades Oncogene Rebecca J. Gum, H Wang et al. 213
7 Effect of PD 098059, a specific inhibitor of mitogen-activated protein kinase kinase, on urokinase expression and in vitro invasion. PubMed Carlos Simón, J. Juárez et al. 50
8 Seroprevalence of parvovirus B19, cytomegalovirus, hepatitis A virus and hepatitis E virus antibodies in haemophiliacs treated exclusively with clotting‐factor concentrates considered safe against human immunodeficiency and hepatitis C viruses Haemophilia J. Juárez, José Bruno Montoro Ronsano et al. 14
9 Up-regulation of urokinase-type plasminogen activator expression by the HER2/neu proto-oncogene. PubMed Rebecca J. Gum, Ernst Lengyel et al. 21
10 Induction of M(r) 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts. PubMed Ernst Lengyel, Rebecca J. Gum et al. 68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026